Literature DB >> 2889494

The protective effects of sulphasalazine against ethanol-induced gastric damage in rats.

C H Cho1, C W Ogle, E L Sevilla.   

Abstract

1 The inhibitory action of sulphasalazine on ethanol-induced gastric damage was studied in rats. 2 Sulphasalazine (62.5 or 125 mg kg-1, s.c.) did not affect basal gastric acid secretion but increased pepsin output. 3 Ethanol (40% v/v, 10 ml kg-1, p.o.) produced severe gastric glandular mucosal damage and lessened the stomach emptying rate of resin pellets, but it increased the levels of prostaglandin E2 (PGE2)-like activity in the glandular mucosa. 4 Sulphasalazine markedly prevented ethanol-induced damage and significantly elevated gastric wall mucus levels both in basal conditions and in the presence of ethanol. 5 Sulphasalazine caused a small insignificant increase in mucosal PGE2 levels in both control and ethanol-treated rats. The drug significantly increased mucosal PGE2 levels in indomethacin-treated animals, but did not prevent indomethacin-induced mucosal damage. 6 Sulphapyridine but not 5-aminosalicylic acid, constituents of sulphasalazine, showed a similar antilesion action to the parent drug, and prevented gastric wall mucus depletion in ethanol-treated animals. 7 This study elucidates the protective effects of sulphasalazine against ethanol-induced gastric lesions. The antagonistic action appears to be mediated, at least partly, through the preservation of gastric wall mucus by sulphapyridine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889494      PMCID: PMC1853607          DOI: 10.1111/j.1476-5381.1987.tb11292.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  A modified hemoglobin substrate method for the estimation of pepsin in gastric juice.

Authors:  A Berstad
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

2.  Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis.

Authors:  J C Sircar; C F Schwender; M E Carethers
Journal:  Biochem Pharmacol       Date:  1983-01-01       Impact factor: 5.858

3.  Proceedings: A method for the quantitative estimation of gastric barrier mucus.

Authors:  S J Corne; S M Morrissey; R J Woods
Journal:  J Physiol       Date:  1974-10       Impact factor: 5.182

4.  Letter: Prostaglandins, ulcerative colitis, and sulphasalazine.

Authors:  S R Gould
Journal:  Lancet       Date:  1975-11-15       Impact factor: 79.321

Review 5.  Clinical pharmacokinetics of sulphasalazine.

Authors:  K M Das; R Dubin
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

6.  Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury.

Authors:  A Robert; J E Nezamis; C Lancaster; A J Hanchar
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

7.  Role of prostaglandins in the formation of aspirin-induced gastric ulcers.

Authors:  S J Konturek; I Piastucki; T Brzozowski; T Radecki; A Dembińska-Kieć; A Zmuda; R Gryglewski
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

8.  Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.

Authors:  S J Konturek; T Radecki; I Piastucki; T Brzozowski; D Drozdowicz
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

9.  Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.

Authors:  J R Hoult; P K Moore
Journal:  Br J Pharmacol       Date:  1980-04       Impact factor: 8.739

10.  A correlative study of the antiulcer effects of zinc sulphate in stressed rats.

Authors:  C H Cho; C W Ogle
Journal:  Eur J Pharmacol       Date:  1978-03-01       Impact factor: 4.432

View more
  6 in total

1.  Anti-ulcer and wound healing activities of Sida corymbosa in rats.

Authors:  Lucy Binda John-Africa; Tijani Adeniyi Yahaya; Christianah Yetunde Isimi
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

Review 2.  Medical treatment of ulcerative colitis: scoring the advances.

Authors:  C J Hawkey; A B Hawthorne
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

3.  Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers.

Authors:  M E McAlindon; A F Muller; B Filipowicz; C J Hawkey
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

4.  A review of the biological and pharmacological activities of mesalazine or 5-aminosalicylic acid (5-ASA): an anti-ulcer and anti-oxidant drug.

Authors:  Mohammad Beiranvand
Journal:  Inflammopharmacology       Date:  2021-08-19       Impact factor: 4.473

Review 5.  Non-steroidal anti-inflammatory drugs in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefit.

Authors:  C Hawkey
Journal:  BMJ       Date:  1989-01-21

6.  Schiff base complexes of copper and zinc as potential anti-colitic compounds.

Authors:  Elaine M Conner; John Reglinski; W Ewen Smith; I Jack Zeitlin
Journal:  Biometals       Date:  2017-04-19       Impact factor: 2.949

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.